MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$60,202K
EPS
-$0.71
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-03-31
Total operating expenses
---42,256
Total revenues
1,083 1,463* 1,666 52
Cost of sales
2,962 -84* 1,577 -
Research and development
43,730 35,980* 27,884 27,467
General and administrative
20,780 16,342* 23,334 14,789
Total operating costs and expenses
67,472 52,237* 52,795 -
Loss from operations
-66,389 -50,774* -51,129 -42,204
Interest income, net
6,288 7,180* 7,421 7,747
Other (expense) income, net
-101 -9* -100 5
Total other income, net
6,187 7,170* 7,321 7,752
Net loss and comprehensive loss
-60,202 -43,605 -43,808 -34,452
Net loss attributable to common stockholders
--43,605 --
Basic EPS
-0.71 -0.552 -0.57 -0.45
Diluted EPS
-0.71 -0.552 -0.57 -0.45
Basic Average Shares
84,518,512 78,992,973 76,729,726 76,187,621
Diluted Average Shares
84,518,512 78,992,973 76,729,726 76,187,621
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income, net$6,288K (-18.83%↓ Y/Y)Net loss andcomprehensive loss-$60,202K (-74.74%↓ Y/Y)Total other income,net$6,187K (-20.19%↓ Y/Y)Commercial And DevelopmentRevenue$1,069K License AndCollaboration Revenue$14K Other (expense)income, net-$101K (-2120.00%↓ Y/Y)Loss from operations-$66,389K (-57.30%↓ Y/Y)Total revenues$1,083K (1982.69%↑ Y/Y)Total operating costsand expenses$67,472K Research and development$43,730K (59.21%↑ Y/Y)General andadministrative$20,780K (40.51%↑ Y/Y)Cost of sales$2,962K

CG Oncology, Inc. (CGON)

CG Oncology, Inc. (CGON)